Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Laure Sayyed Kassem & David C. Aron. (2020) The assessment and management of quality of life of older adults with diabetes mellitus. Expert Review of Endocrinology & Metabolism 15:2, pages 71-81.
Read now
Read now
Yingnan Zhao, Qian Shi, Yao Wang, Vivian Fonseca & Lizheng Shi. (2016) Economic burden of hypoglycemia: Utilization of emergency department and outpatient services in the United States (2005–2009). Journal of Medical Economics 19:9, pages 852-857.
Read now
Read now
Jing Deng, Shuyan Gu, Hui Shao, Hengjin Dong, Dajin Zou & Lizheng Shi. (2015) Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies. Journal of Medical Economics 18:11, pages 974-989.
Read now
Read now
Antoni Sicras-Mainar & Ruth Navarro-Artieda. (2014) Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly. Drug Design, Development and Therapy 8, pages 811-818.
Read now
Read now
Daniel Viriato, Frederico Calado, Jean-Bernard Gruenberger, Siew Hwa Ong, Davide Carvalho, José Silva-Nunes, Sukhvinder Johal & Ricardo Viana. (2014) Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective. Journal of Medical Economics 17:7, pages 499-507.
Read now
Read now
Matthew L. Mintz & Gianmaria Minervini. (2014) Saxagliptin versus glipizide as add-on therapy to metformin: assessment of hypoglycemia. Current Medical Research and Opinion 30:5, pages 761-770.
Read now
Read now
Wei Shao, Rabia Ahmad, Naum Khutoryansky, Mark Aagren & Jonathan Bouchard. (2013) Evidence supporting an association between hypoglycemic events and depression. Current Medical Research and Opinion 29:12, pages 1609-1615.
Read now
Read now
Articles from other publishers (22)
Hui Shao, Lizheng Shi, Vivian Fonseca, Abdul Jabbar Omar Alsaleh, Jasvinder Gill & Charlie Nicholls. (2023) Cost‐effectiveness analysis of once‐daily insulin glargine 300 U/mL versus insulin degludec 100 U/mL using the BRAVO diabetes model. Diabetic Medicine 40:9.
Crossref
Crossref
Chuanyu Guo, Monika Deshpande, Yueqi Niu, Isha Kachwala, Miguel Flores-Bellver, Haley Megarity, Taylor Nuse, Savalan Babapoor-Farrokhran, Michael Ramada, Jaron Sanchez, Neelay Inamdar, Thomas V. Johnson, Maria Valeria Canto-Soler, Silvia Montaner & Akrit Sodhi. (2023) HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease. Cell Reports 42:1, pages 111976.
Crossref
Crossref
Lawrence Blonde, Guillermo E. Umpierrez, S. Sethu Reddy, Janet B. McGill, Sarah L. Berga, Michael Bush, Suchitra Chandrasekaran, Ralph A. DeFronzo, Daniel Einhorn, Rodolfo J. Galindo, Thomas W. Gardner, Rajesh Garg, W. Timothy Garvey, Irl B. Hirsch, Daniel L. Hurley, Kenneth Izuora, Mikhail Kosiborod, Darin Olson, Shailendra B. Patel, Rodica Pop-Busui, Archana R. Sadhu, Susan L. Samson, Carla Stec, William V. TamborlaneJr.Jr., Katherine R. Tuttle, Christine Twining, Adrian Vella, Priyathama Vellanki & Sandra L. Weber. (2022) American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocrine Practice 28:10, pages 923-1049.
Crossref
Crossref
Lucas A. Myers, Kristi M. Swanson, Amy E. Glasgow & Rozalina G. McCoy. (2022) Management and Outcomes of Severe Hypoglycemia Treated by Emergency Medical Services in the U.S. Upper Midwest. Diabetes Care 45:8, pages 1788-1798.
Crossref
Crossref
Scott J. Pilla, Samantha I. Pitts & Nisa M. Maruthur. (2022) High Concurrent Use of Sulfonylureas and Antimicrobials With Drug Interactions Causing Hypoglycemia. Journal of Patient Safety 18:1, pages e217-e224.
Crossref
Crossref
Lizheng Shi, Vivian Fonseca & Belinda Childs. (2021) Economic burden of diabetes-related hypoglycemia on patients, payors, and employers. Journal of Diabetes and its Complications 35:6, pages 107916.
Crossref
Crossref
Grace K. Mahoney, Henry J. Henk & Rozalina G. McCoy. (2019) Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes. Mayo Clinic Proceedings 94:9, pages 1731-1742.
Crossref
Crossref
Fatima Al Sayah, Roseanne O. Yeung & Jeffrey A. Johnson. (2019) Association of Depressive Symptoms and Diabetes Distress With Severe Hypoglycemia in Adults With Type 2 Diabetes. Canadian Journal of Diabetes 43:5, pages 316-321.
Crossref
Crossref
Domingo Orozco-Beltrán, Sara Artola, Margarida Jansà, Martin Lopez de la Torre-Casares & Eva Fuster. (2018) Impact of hypoglycemic episodes on health-related quality of life of type-2 diabetes mellitus patients: development and validation of a specific QoLHYPO© questionnaire. Health and Quality of Life Outcomes 16:1.
Crossref
Crossref
Richard Silbert, Alejandro Salcido-Montenegro, Rene Rodriguez-Gutierrez, Abdulrahman Katabi & Rozalina G. McCoy. (2018) Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Current Diabetes Reports 18:8.
Crossref
Crossref
Simon J. Fisher, Xingyue Huang, Manjiri Pawaskar, Edward A. Witt, Swapnil Rajpathak, R. Ravi Shankar & Silvio E. Inzucchi. (2018) Hypoglycemia in type 2 diabetes: understanding patients’ and physicians’ knowledge and experience. Endocrine 60:3, pages 435-444.
Crossref
Crossref
Berhanu Alemayehu, Jinan Liu, Swapnil Rajpathak & Samuel S. Engel. (2017) Healthcare resource use and associated costs of hypoglycemia in patients with type 2 diabetes prescribed sulfonylureas. Journal of Diabetes and its Complications 31:11, pages 1620-1623.
Crossref
Crossref
Chris J. Alexiu, Anderson Chuck, Susan E. Jelinski & Brian H. Rowe. (2017) Presentations for hypoglycemia associated with diabetes mellitus to emergency departments in a Canadian province: A database and epidemiological analysis. Diabetes Research and Clinical Practice 130, pages 229-236.
Crossref
Crossref
Gyuri Kim, Yong-ho Lee, Mi Hye Han, Eui-Kyung Lee, Chong Hwa Kim, Hyuk Sang Kwon, In Kyung Jeong, Eun Seok Kang & Dae Jung Kim. (2016) Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea. PLOS ONE 11:3, pages e0151282.
Crossref
Crossref
Yingnan. Zhao, Sumesh. Kachroo, Hugh. Kawabata, Susan. Colilla, Jayanti. Mukherjee, Vivian. Fonseca, Uchenna. Iloeje & Lizheng. Shi. (2016) Association Between Hypoglycemia And Fall-Related Fractures And Health Care Utilization In Older Veterans With Type 2 Diabetes. Endocrine Practice 22:2, pages 196-204.
Crossref
Crossref
L. Tao, E. C. F. Wilson, N. J. Wareham, A. Sandbæk, G. E. H. M. Rutten, T. Lauritzen, K. Khunti, M. J. Davies, K. Borch‐Johnsen, S. J. Griffin & R. K. Simmons. (2015)
Cost‐effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen‐detected Type 2 diabetes: analysis of the
ADDITION
‐
UK
cluster‐randomized controlled trial
. Diabetic Medicine 32:7, pages 907-919.
Crossref
Crossref
Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger, Guillermo Umpierrez, Robert S. Zimmerman, Timothy S. Bailey, Lawrence Blonde, George A. Bray, A. Jay Cohen, Samuel Dagogo-Jack, Jaime A. Davidson, Daniel Einhorn, Om P. Ganda, Alan J. Garber, W. Timothy Garvey, Robert R. Henry, Irl B. Hirsch, Edward S. Horton, Daniel L. Hurley, Paul S. Jellinger, Lois Jovanovič, Harold E. Lebovitz, Derek LeRoith, Philip Levy, Janet B. McGill, Jeffrey I. Mechanick, Jorge H. Mestman, Etie S. Moghissi, Eric A. Orzeck, Rachel Pessah-Pollack, Paul D. Rosenblit, Aaron I. Vinik, Kathleen Wyne & Farhad Zangeneh. (2015) American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015. Endocrine Practice 21, pages 1-87.
Crossref
Crossref
Danny Meetoo. (2014) Diabetes: complications and the economic burden. British Journal of Healthcare Management 20:2, pages 60-67.
Crossref
Crossref
A. Sicras Mainar, C. Roldán Suárez, B. Font Ramos, R. Navarro Artieda & J. Ibáñez Nolla. (2013) Clinical and economical consequences of the combination of metformin with dipeptidyl peptidase inhibitors in type 2 diabetes patients. Revista Clínica Española (English Edition) 213:8, pages 377-384.
Crossref
Crossref
A. Sicras Mainar, C. Roldán Suárez, B. Font Ramos, R. Navarro Artieda & J. Ibáñez Nolla. (2013) Consecuencias clínicas y económicas de la combinación de metformina con inhibidores de la dipeptidilpeptidasa en pacientes con diabetes tipo 2. Revista Clínica Española 213:8, pages 377-384.
Crossref
Crossref
Etie Moghissi, Faramarz Ismail-Beigi & Robin Cammarota Devine. (2013) Hypoglycemia: Minimizing Its Impact in Type 2 Diabetes. Endocrine Practice 19:3, pages 526-535.
Crossref
Crossref
James R. LaSalle. (2013) Enhancing treatment success with incretin-based therapies: A comprehensive approach to the patient with diabetes. Osteopathic Family Physician 5:1, pages 51-57.
Crossref
Crossref